PLAY PODCASTS
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer

Research To Practice | Oncology Videos · Dr. Neil Love

August 5, 20241h 0m

Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Featuring perspectives from Dr Matthew Gubens, including the following topics:

  • Introduction: Risk of Autoimmune Toxicity with Checkpoint Inhibitors (0:00)
  • Immunotherapy in the Neoadjuvant/Adjuvant Setting (7:33)
  • Immunotherapy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (15:45)
  • First-Line Immunotherapy for Metastatic NSCLC (24:04)
  • Novel Agents and Strategies (30:39)
  • Immunotherapy for NSCLC with a Targetable Mutation (41:34)
  • Small Cell Lung Cancer (47:06)

CME information and select publications